Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 15/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CXCR1 | P25024 | 11/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CCR6 | P51684 | 2/20 | 0.40 |
| ▸ | CCR7 | P32248 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21803030 | 1.00 | CXCR2 (0.49) | CXCR2GAAPOLBCXCR1MAPT | |
| SCHEMBL13075315 | 0.89 | CXCR2 (0.57) | CXCR2GAAPOLBCXCR1MAPT | |
| SCHEMBL30631981 | 0.89 | CXCR2 (0.57) | CXCR2GAAPOLBCXCR1MAPT | |
| SCHEMBL23610482 | 0.89 | CXCR2 (0.57) | CXCR2GAAPOLBCXCR1MAPT | |
| SCHEMBL21803167 | 0.87 | GAA (0.50) | CXCR2GAAPOLBCXCR1MAPT | |
| SCHEMBL30631989 | 0.87 | GAA (0.50) | CXCR2GAAPOLBCXCR1MAPT | |
| SCHEMBL23220275 | 0.82 | CXCR2 (0.48) | CXCR2CXCR1CCR6CCR7 | |
| SCHEMBL12261147 | 0.82 | CXCR2 (0.63) | CXCR2GAACXCR1CCR6 | |
| SCHEMBL21803113 | 0.73 | GAA (0.51) | CXCR2GAAPOLBMAPT | |
| SCHEMBL20732789 | 0.72 | GAA (0.60) | CXCR2GAAPOLBCXCR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116874466-B | N-substituted dioxocyclobutylamino-3-hydroxy-pyridinecarboxamides as CCR6 inhibitors | PFIZER INC. (US) | 2026-05-26 | — | — | CN | disclosed |
| CN-116874466-A | N-substituted dioxocyclobutylamino-3-hydroxy-pyridinecarboxamides as CCR6 inhibitors | 辉瑞公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-112672791-B | N-substituted dioxocyclobutylamino-3-hydroxy-pyridinecarboxamides as CCR6 inhibitors | 辉瑞公司 | 2023-10-03 | — | — | CN | disclosed |